| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |